Extracellular matrix as a strategy for treating chronic wounds

American Journal of Clinical Dermatology

Volumn 8, Issue 2, 2007, Pages 61-66

  Hodde, Jason P ^a   Johnson, Chad E ^a  

^a Cook Biotech Incorporated ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; FIBRONECTIN; GROWTH FACTOR; HEPARIN; HYALURONIC ACID; MATRIX METALLOPROTEINASE; OXIDIZED REGENERATED CELLULOSE; RECOMBINANT PLATELET DERIVED GROWTH FACTOR;

CHRONIC WOUND; DERMIS; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; PRIORITY JOURNAL; REVIEW; SKIN INJURY; TISSUE REGENERATION; WOUND CARE; WOUND DRESSING; WOUND HEALING; BANDAGE; CHRONIC DISEASE; SKIN ULCER;

BIOLOGICAL DRESSINGS; CHRONIC DISEASE; EXTRACELLULAR MATRIX; HUMANS; SKIN ULCER; WOUND HEALING;

EID: 34250667632     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200708020-00001     Document Type: Review

References (71)

1. Pham HT, Economides PA, Veves A. The role of endothelial function on the foot: microcirculation and wound healing in patients with diabetes. Clin Podiatr Med Surg 1998; 15: 85-93
2. Guillot B, Dandurand M, Guilhou JJ. Skin perfusion pressure in leg ulcers assessed by photoplethysmography. Int Angiol 1988; 7: 33-4
3. Schubert V, Perbeck L, Schubert PA. Skin microcirculatory and thermal changes in elderly subjects with early stage of pressure sores. Clin Physiol 1994; 14: 1-13
4. Margolis DJ, Allen-Taylor L, Hoffstad O, et al. Healing diabetic neuropathic foot ulcers: are we getting better? Diabet Med 2005; 22: 172-6
5. Franks PJ, Moffatt CJ. Health related quality of life in patients with venous ulceration: use of the Nottingham health profile. Qual Life Res 2001; 10: 693-700
6. Thomas DR, Diebold MR, Eggemeyer LM. A controlled, randomized, comparative study of a radiant heat bandage on the healing of stage 3-4 pressure ulcers: a pilot study. J Am Med Dir Assoc 2005; 6: 46-9
7. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 2002; 137: 822-7
8. Centers for Disease Control and Prevention. National diabetes surveillance system [online]. Available from URL: http://www.cdc.gov/diabetes/ statistics/prev/national/figpersons.htm [Accessed 2007 Feb 6]
9. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999; 22: 382-7
10. Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003; 26: 1790-5
11. Margolis DJ, Bilker W, Santanna J, et al. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 2002; 46: 381-6
12. Olin JW, Beusterien KM, Childs MB, et al. Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study. Vasc Med 1999; 4: 1-7
13. Amlung SR, Miller WL, Bosley LM. The 1999 National Pressure Ulcer Prevalence Survey: a benchmarking approach. Adv Skin Wound Care 2001; 14: 297-301
14. National Pressure Ulcer Advisory Panel. Pressure ulcers in America: prevalence, incidence, and implications for the future: an executive summary of the National Pressure Ulcer Advisory Panel monograph. Adv Skin Wound Care 2001; 14: 208-15
15. Beckrich K, Aronovitch SA. Hospital-acquired pressure ulcers: a comparison of costs in medical vs. surgical patients. Nurs Econ 1999; 17: 263-71
16. Hareendran A, Bradbury A, Budd J, et al. Measuring the impact of venous leg ulcers on quality of life. J Wound Care 2005; 14: 53-7
17. Nabuurs-Franssen MH, Huijberts MS, Nieuwenhuijzen Kruseman AC, et al. Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia. Epub 2005 Jul 2
18. Sottile J, Hocking DC. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 2002; 13: 3546-59
19. Akiyama SK. Integrins in cell adhesion and signaling. Hum Cell 1996; 9: 181-6
20. Raman R, Sasisekharan V, Sasisekharan R. Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem Biol 2005; 12: 267-77
21. Takehara K. Growth regulation of skin fibroblasts. J Dermatol Sci 2000; 24: S70-7
22. Tang A, Gilchrest BA. Regulation of keratinocyte growth factor gene expression in human skin fibroblasts. J Dermatol Sci 1996; 11: 41-50
23. Xue M, Le NT, Jackson CJ. Targeting matrix metalloproteases to improve cutaneous wound healing. Expert Opin Ther Targets 2006; 10 (1): 143-55
24. Holbrook KA, Smith LT. Morphology of connective tissue: structure of skin and tendon. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable diseases. New York: Wiley-Liss, 1993: 51-71
25. Garrone R, Lethias C, Le Guellec D. Distribution of minor collagens during skin development. Microsc Res Tech 1997; 38: 407-12
26. Keene DR, Marinkovich MP, Sakai LY. Immunodissection of the connective tissue matrix in human skin. Microsc Res Tech 1997; 38: 394-406
27. Ayers CE, Bowlin GL, Simpson DG. Microvascular endothelial cell migration in scaffolds of electrospun collagen. Wound Repair Regen 2005; 13: A4-27
28. Pizzo AM, Kokini K, Vaughn LC, et al. Extracellular matrix (ECM) microstructural composition regulates local cell-ECM biomechanics and fundamental fibroblast behavior: a multidimensional perspective. J Appl Physiol 2005; 98: 1909-21
29. Bonaldo P, Russo V, Bucciotti F, et al. Structural and functional features of the alpha 3 chain indicate a bridging role for chicken collagen VI in connective tissues. Biochemistry 1990; 29: 1245-54
30. Bruns R, Press W, Engvall E, et al. Type VI collagen in extracellular, 100nm periodic filaments and fibrils: identification by immunoelectron microscopy. J Cell Biol 1986; 103: 393-404
31. Bruns RR. Beaded filaments and long-spacing fibrils: relation to type VI collagen. J Ultrastr Res 1984; 89: 136-46
32. Bidanset DJ, Guidry C, Rosenberg LC, et al. Binding of the proteoglycan decorin to collagen type VI. J Biol Chem 1992; 267: 5250-66
33. Kielty CM, Whittaker SP, Grant ME, et al. Type VI collagen microfibrils: evidence for a structural association with hyaluronan. J Cell Biol 1992; 118: 979-90
34. Kielty CM, Whittaker SP, Grant ME, et al. Attachment of human vascular smooth muscle cells to intact microfibrillar assemblies of collagen VI and fibrillin. J Cell Sci 1992; 103: 445-51
35. Kielty CM, Lees M, Shuttleworth CA, et al. Catabolism of intact type VI collagen microfibrils: susceptibility to degradation by serine proteinases. Biochem Biophys Res Commun 1993; 191: 1230-6
36. Levine JM, Nishiyama A. The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells. Perspect Dev Neurobiol 1996; 3: 245-59
37. Eckes B, Zweers MC, Zhang ZG, et al. Mechanical tension and integrin alpha2beta1 regulate fibroblast functions. J Investig Dermatol Symp Proc 2006; 11: 66-72
38. Zweers MC, Davidson JM, Pozzi A, et al. Integrin alpha2beta1 is required for regulation of murine wound angiogenesis but is dispensable for reepithelialization. J Invest Dermatol 2007; 127: 467-78
39. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990; 346: 281-4
40. Pasco S, Ramont L, Maquart FX, et al. Biological effects of collagen I and IV peptides. J Soc Biol 2003; 197: 31-9
41. Debelle L, Tamburro AM. Elastin: molecular description and function. Int J Biochem Cell Biol 1999; 31: 261-72
42. Kumar V, Fausto N, Abbas A. Robbins & Cotran pathologic basis of disease. 7th ed. Philadelphia (PA): Elsevier Saunders, 2005
43. Sephel GC, Kennedy R, Kudravi S. Expression of capillary basement membrane components during sequential phases of wound angiogenesis. Matrix Biol 1996; 15: 263-79
44. Schneider H, Muhle C, Pacho F. Biological function of laminin-5 and pathogenic impact of its deficiency. Eur J Cell Biol. Epub 2006 Sep 23
45. Olutoye OO, Barone EJ, Yager DR, et al. Hyaluronic acid inhibits fetal platelet function: implications in scarless healing. J Pediatr Surg 1997; 32: 1037-40
46. Quarto N, Amalric F. Heparan sulfate proteoglycans as transducers of FGF-2 signalling. J Cell Sci 1994; 107: 3201-12
47. Tabibzadeh S. Homeostasis of extracellular matrix by TGF-beta and lefty. Front Biosci 2002; 7: d1231-46
48. Inkinen K, Wolff H, Lindroos P, et al. Connective tissue growth factor and its correlation to other growth factors in experimental granulation tissue. Connect Tissue Res 2003; 44: 19-29
49. Yoshida K, Munakata H. Connective tissue growth factor binds to fibronectin through the type I repeat modules and enhances the affinity of fibronectin to fibrin. Biochim Biophys Acta. Epub 2006 Nov 30
50. Presta M, Dell'era P, Mitola S, et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 2005; 16: 159-78
51. Kantor J, Margolis DJ. Expected healing rates for chronic wounds. Wounds 2000; 12: 155-8
52. Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999; 7: 442-52
53. Clark RA. Fibrin and wound healing. Ann N Y Acad Sci 2001; 936: 355-67
54. Quatresooz P, Henry F, Paquet P, et al. Deciphering the impaired cytokine cascades in chronic leg ulcers [review]. Int J Mol Med 2003; 11: 411-8
55. Van de Berg JS, Robson MC. Arresting cell cycles and the effect on wound healing. Surg Clin North Am 2003; 83: 509-20
56. Cook H, Davies KJ, Harding KG, et al. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol 2000; 115: 225-33
57. Kim BC, Kim HT, Park SH, et al. Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta type II receptor expression. J Cell Physiol 2003; 195: 331-6
58. Wysocki AB, Grinnell F. Fibronectin profiles in normal and chronic wound fluid. Lab Invest 1990; 63: 825-31
59. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993; 101: 64-8
60. Ongenae KC, Phillips TJ, Park HY. Level of fibronectin mRNA is markedly increased in human chronic wounds. Dermatol Surg 2000; 26: 447-51
61. Ellerbroek SM, Wu YI, Stack MS. Type I collagen stabilization of matrix metalloproteinase-2. Arch Biochem Biophys 2001; 390: 51-6
62. Cullen B, Smith R, McCulloch E, et al. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 2002; 10: 16-25
63. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes Care 1998; 21: 822-7
64. Margolis DJ, Kantor J, Berlin JA. Healing of diabetic neuropathic foot ulcers receiving standard treatment: a meta-analysis. Diabetes Care 1999; 22: 692-5
65. Solomon DE. An in vitro examination of an extracellular matrix scaffold for use in wound healing. Int J Exp Pathol 2002; 83: 209-16
66. Leipziger LS, Glushko V, DiBernardo B, et al. Dermal wound repair: role of collagen matrix implants and synthetic polymer dressings. J Am Acad Dermatol 1985; 12: 409-19
67. Gao ZR, Hao ZQ, Li Y, et al. Porcine dermal collagen as a wound dressing for skin donor sites and deep partial skin thickness burns. Burns 1992; 18: 492-6
68. Lobmann R, Zemlin C, Motzkau M, et al. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications 2006; 20: 329-35
69. Hodde JP, Badylak SF, Brightman AO, et al. Glycosaminoglycan content of small intestinal submucosa: a bioscaffold for tissue replacement. Tissue Eng 1996; 2: 209-17
70. Niezgoda JA, Van Gils CC, Frykberg RG, et al. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care 2005; 18: 258-66
71. Mostow EN, Haraway GD, Dalsing M, et al. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 2005; 41: 856-62